Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors

Abstract

The present invention is directed to novel benzothiazo and related heterocyclic group-containing inhibitors of cysteine or serine proteases. Methods for using the same are also described.

Claims

1. A compound having the formula: ##STR21## wherein: A--B represents one, two, or three carbon atoms or nitrogen atoms, optionally connected by single bonds or one double bond, optionally substituted with one or more groups selected from the group consisting of R.sup.3, R.sup.4, OR.sup.3, OR.sup.4, R.sup.4a, and OR.sup.4a, with the proviso that the number of nitrogen atoms is 0, 1 or 2;

R.sup.1 and R.sup.2 are each independently hydrogen, alkyl having from one to 14 carbons, cycloalkyl having from 3 to 10 carbons, aryl having from 6 to about 14 carbons, heteroaryl having from 6 to about 14 ring atoms, aralkyl having from 7 to 15 carbons, heteroaralkyl, or an optionally protected natural or unnatural side chain of an amino acid, said alkyl, cycloalkyl, aryl, and heteroaryl groups being optionally substituted with one or more K groups;

R.sup.3, R.sup.4 and R.sup.4a are each independently hydrogen, lower alkyl, or a natural or unnatural side chain of an optionally protected amino acid, said alkyl groups being optionally substituted with an aryl or heteroaryl group;

R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are each independently hydrogen, alkyl having from one to 14 carbons wherein said alkyl groups are optionally substituted with one or more K groups, alkoxy having from one to 10 carbons, halogen, alkoxycarbonyl, carboxyl, hydroxyl, heterocyclic, or amino optionally substituted with 1 to 3 aryl or lower alkyl groups;

or any two adjacent R.sup.5, R.sup.6, R.sup.7 and R.sup.8 groups taken together with any intervening atoms of the benzene ring to which they are attached form an alicyclic, aromatic, heterocyclic, or heteroaryl ring having 5 to 8 ring atoms;

K is halogen, lower alkyl, lower alkenyl, aryl, heterocyclic, guanidino, nitro, alkoxycarbonyl, alkoxy, hydroxyl, carboxyl, arylaminosulfonyl, heteroarylaminosulfonyl, alkylaminosulfonyl, or amino optionally substituted with an alkylsulfonyl, arylsulfonyl, or heteroarylsulfcnyl group, or with 1 to 3 aryl or lower alkyl groups, said alkyl, aryl, and heteroaryl groups being optionally substituted with one or more G groups;

G is the same as K;

Y is O, NH, NR.sup.9 or CHR.sup.9;

Z is S(.dbd.O)).sub.2, S(.dbd.O), S, or C(.dbd.O);

j is 0, 1 or 2;

Q is hydrogen, C(.dbd.O)NHR.sup.9, C(.dbd.O)OR.sup.9, CH.dbd.N.sub.2, or CH.sub.2 R.sup.10;

R.sup.9 is hydrogen, alkyl having from one to 10 carbons, said alkyl groups being optionally substituted with one or more K groups, aryl having from 6 to 14 carbons, or aralkyl having from 7 to 15 carbons;

R.sup.10 is aryloxy, heteroaryloxy, L, halogen, or has the formula O--M, wherein M has the structure: ##STR22## wherein: R is N or CR.sup.11;

W is a double bond or a single bond;

D is C.dbd.O or a single bond;

E and F are independently R.sup.12, R.sup.13, or J;

or E and F taken together comprise a joined moiety, said joined moiety being an aliphatic carbocyclic ring optionally substituted with J and having from 5 to 7 carbons, an aromatic carbocyclic ring optionally substituted with J and having from 5 to 7 carbons, an aliphatic heterocyclic ring optionally substituted with J and having from 5 to 7 atoms, or an aromatic heterocyclic ring optionally substituted with J and having from 5 to 7 atoms, said aliphatic heterocyclic ring or said aromatic heterocyclic ring each having from 1 to 4 heteroatoms;

R.sup.11, R.sup.12, and R.sup.13 are independently H, alkyl having from 1 to 10 carbons, heteroaryl having from 1 to 10 carbons, alkanoyl having from 1 to 10 carbons, or aroyl, wherein said alkyl, heteroaryl, alkanoyl and aroyl groups are optionally substituted with J;

J is halogen, C(.dbd.O)OR.sup.14, R.sup.14 OC(.dbd.O), R.sup.14 OC(.dbd.O)NH, OH, CN, NO.sub.2, NR.sup.14 R.sup.15, N.dbd.C(R.sup.14)R.sup.15, N.dbd.C(NR.sup.14 R.sup.15).sub.2, SR.sup.14, OR.sup.14, phenyl, napthy heteroaryl, or a cycloalkyl group having from 3 to 8 carbons;

R.sup.14 and R.sup.15 are independently H, alkyl having from 1 to 10 carbons, aryl, or heteroaryl, wherein said alkyl, aryl and heteroaryl groups are optionally substituted with K;

L is a phosphorus-containing enzyme reactive group having the formula: ##STR23## wherein: m, n, and b are each independently 0 or 1;

R.sup.16 and R.sup.17 are each independently hydrogen, lower alkyl optionally substituted with K, aryl optionally substituted with K, or heteroaryl optionally substituted with K;

or R.sup.16 and R.sup.17 taken together with --(O).sub.n --P(.dbd.O)--(O).sub.m -- can form a 5-8 membered ring containing up to 3 hetero atoms;

or R.sup.16 and R.sup.17 taken together with --(O).sub.n --P(.dbd.O)--(O).sub.m - can form a 5-8 membered ring optionally substituted with K;

or a pharmaceutically acceptable salt or bisulfite addition product thereof.

4. The compound of claim 3 wherein R.sup.3 and R.sup.4 are each H.

5. The compound of claim 1 wherein Z is SO.sub.2 or C(.dbd.O).

6. The compound of claim 5 wherein Z is SO.sub.2.

7. The compound of claim 1 wherein R.sup.2, R.sup.5 and R.sup.8 are each H.

8. The compound of claim 1 wherein R.sup.1 is alkyl or aralkyl.

9. The compound of claim 8 wherein R.sup.1 is i-butyl or benzyl.

10. The compound of claim 1 wherein R.sup.6 and R.sup.7 are independently H, alkoxy, halogen, or heterocyclic, or R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 --O--.

11. The compound of claim 10 wherein R.sup.6 and R.sup.7 are independently H, --OCH.sub.3, F, Cl, or morpholin-4-yl, or R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 O--.

12. The compound of claim 1 wherein Q is H, C(.dbd.O)NHR.sup.9, or C(.dbd.O)OR.sup.9, where R.sup.9 is alkyl or alkyl substituted with K.

13. The compound of claim 1 wherein Y is O, NH, NR.sup.9 or CHR.sup.9, where R.sup.9 is alkyl or aralkyl.

14. The compound of claim 13 wherein Y is NR.sup.9 or CHR.sup.9, where R.sup.9 is methyl ethyl, propyl, i-butyl or benzyl.

16. The compound of claim 15 wherein Z is SO.sub.2.

17. The compound of claim 15 wherein R.sup.1 is i-butyl or benzyl.

18. The compound of claim 15 wherein R.sup.6 and R.sup.7 are independently H, --OCH.sub.3, F, Cl, or morpholin-4-yl, or R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 O--.

19. The compound of claim 15 wherein Y is NR.sup.9 or CHR.sup.9, where R.sup.9 is methyl ethyl, propyl, i-butyl or benzyl.

20. The compound of claim 15 wherein A--B is --CH.sub.2 --CH--.

21. The compound of claim 1 having the formula: ##STR24## wherein: R.sup.1 is alkyl, alkyl substituted with K, or aralkyl;

R.sup.6 and R.sup.7 are independently H, alkoxy, halogen, or heterocyclic, or R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 --O--;

Q is H, C(.dbd.O)NHR.sup.9, or C(.dbd.O)OR.sup.9, where R.sup.9 is alkyl; and

Y is O, NH or NR.sup.9 where R.sup.9 is alkyl or aralkyl.

22. The compound of claim 21 wherein R.sup.1 is i-butyl, benzyl, or alkyl substituted with phenylsulfonyl-amino.

23. The compound of claim 21 wherein R.sup.6 and R.sup.7 are independently H, OCH.sub.3, F, Cl, or morpholin-4-yl, or R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 O--.

24. The compound of claim 21 wherein Q is C(.dbd.O)NHR.sup.9, or C(.dbd.O)OR.sup.9, where R.sup.9 is methyl, ethyl, or butyl.

25. The compound of claim 21 wherein Y is O, NH or NR.sup.9, wherein R.sup.9 is methyl, ethyl, i-propyl, i-butyl or benzyl.

26. The compound of claim 21 wherein R.sup.1, R.sup.6, R.sup.7, Y and Q have the values shown in the horizontal rows of the following table:

27. The compound of claim 1 having the formula: ##STR25## wherein: R.sup.1 is benzyl;

R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 O--;

Y is N-H or NR.sup.9 wherein R.sup.9 is ethyl; and

Q is C(.dbd.O)NHR.sup.9 where R.sup.9 is alkyl or alkyl substituted with K.

28. The compound of claim 27 wherein Q is CONHEt, CONHBu, CONHCH.sub.2 CH.sub.2 OCH.sub.3, CONHCH(CH.sub.3).sub.2, CONH(CH.sub.2).sub.4 CH.sub.3, CONHCH.sub.2 Ph, CONHCH.sub.2 CH.sub.2 Ph, CONHCH.sub.2 CH.dbd.CH.sub.2, CONH(CH.sub.2).sub.3 -(imidazol-1-yl), CONH (CH.sub.2).sub.3 -(2-ketopyrrolidin-1-yl), CONH(CH.sub.2).sub.3 (morpholin-4-yl), CONHCH.sub.2 (pyridin-2-yl), CONHCH.sub.2 -cyclopropane, CONHCH.sub.2 CH.sub.2 NHSO.sub.2 CH.sub.3, CONHCH.sub.2 CH.sub.2 NHSO.sub.2 (4--NO.sub.2 -Ph), CONH(CH.sub.2).sub.3 NHSO.sub.2 (4--NO.sub.2 -Ph), CONHCH.sub.2 CH.sub.2 NHSO.sub.2 (3,4--Cl.sub.2 -Ph), CONH(CH.sub.2).sub.3 NHSO.sub.2 (3,4--Cl.sub.2 -Ph), CONHCH.sub.2 CH.sub.2 NHSO.sub.2 Ph, CONHCH.sub.2 CH.sub.2 NHSO.sub.2 (5-(2-pyridinyl)-thiophen-2-yl), CONH (CH.sub.2).sub.3 NHSO.sub.2 (4-F-Ph), CONH(CH.sub.2).sub.3 NHSO.sub.2 Ph, CONHCH.sub.2 -(pyridin-4-yl), or CONHCH.sub.2 CH.sub.2 NHSO.sub.2 (4-F-Ph).

29. The compound of claim 27 wherein Y and Q have the values shown in the horizontal rows of the following table:

30. The compound of claim 1 having the formula: ##STR26## wherein: R.sup.1 is benzyl;

R.sup.6 and R.sup.7 are independently H or halogen, or R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 --O--;

R.sup.4 is H, alkoxy, or hydroxy;

Y is NR.sup.9 wherein R.sup.9 is alkyl; and

Q is H or C(.dbd.O)NHR.sup.9 where R.sup.9 is alkyl.

31. The compound of claim 30 wherein Q is H or CONHBu.

32. The compound of claim 30 wherein R.sup.6 and R.sup.7 are independently H or Cl, or R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 --O--.

33. The compound of claim 30 wherein R.sup.4 is H, methoxy, or hydroxy.

34. The compound of claim 30 wherein Y is NR.sup.9 wherein R.sup.9 is methyl or ethyl.

35. The compound of claim 30 wherein Y, Q, R.sup.1, R.sup.4, R.sup.6 and R.sup.7 have the values shown in the horizontal rows of the following table:

36. The compound of claim 1 having the formula: ##STR27## wherein: R.sup.1 is benzyl;

R.sup.6 and R.sup.7 are each H;

R.sup.4 is H, alkyl, or aralkyl;

R.sup.9 is alkyl; and

Q is H or C(.dbd.O)NHR.sup.9 where R.sup.9 is alkyl.

37. The compound of claim 36 wherein R.sup.4 is H, propyl, or benzyl.

38. The compound of claim 36 wherein Q is H or CONHBu.

39. The compound of claim 36 wherein R.sup.9 is ethyl or ethyl.

40. The compound of claim 36 wherein R.sup.4, R.sup.9 and Q have the values shown in the horizontal rows of the following table:

41. The compound of claim 1 having the formula: ##STR28## wherein: R.sup.1 is benzyl;

R.sup.6 and R.sup.7 are each H, or R.sup.6 and R.sup.7 taken together form --O--CH.sub.2 --CH.sub.2 --O--; and

Q is H or C(.dbd.O)NHR.sup.9 where R.sup.9 is alkyl.

42. The compound of claim 41 wherein Q is H or CONHBu.

43. The compound of claim 41 wherein R.sup.6, R.sup.7 and Q have the values shown in the horizontal rows of the following table:

44. The compound of claim 1 having the formula: ##STR29## wherein: R.sup.1 is benzyl;

R.sup.6 and R.sup.7 are each H;

Q is H; and

R.sup.9 is H or alkyl.

45. The compound of claim 44 wherein R.sup.9 is H or CH.sub.3.

46. The compound of claim 1 having the formula: ##STR30## wherein: R.sup.1 and R.sup.2 are each independently hydrogen, alkyl having from one to about 14 carbons, cycloalkyl having from 3 to about 10 carbons, aryl having from about 6 to about 14 carbons, heteroaryl having from about 6 to about 14 ring atoms, aralkyl having from about 7 to about 15 carbons, heteroaralkyl, or an optionally protected natural or unnatural side chain of an amino acid, said alkyl, cycloalkyl, aryl, and heteroaryl groups being optionally substituted with one or more K groups;

R.sup.3 and R.sup.4 are each independently hydrogen, lower alkyl, or a natural or unnatural side chain of an optionally protected amino acid, said alkyl groups being optionally substituted with an aryl or heteroaryl group;

R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are each independently hydrogen, alkyl having from one to about 14 carbons wherein said alkyl groups are optionally substituted with one or more K groups, alkoxy having from one to about 10 carbons, halogen, alkoxycarbonyl, carboxyl, hydroxyl, or amino optionally substituted with 1 to 3 aryl or lower alkyl groups;

or any two adjacent R.sup.5, R.sup.6, R.sup.7 and R.sup.8 groups taken together with any intervening atoms of the benzene ring to which they are attached form an alicyclic, aromatic, heterocyclic, or heteroaryl ring having 5 to 8 ring atoms;

K is halogen, lower alkyl, aryl, heteroaryl, guanidino, alkoxycarbonyl, alkoxy, hydroxyl, carboxyl, or amino optionally substituted with 1 to 3 aryl or lower alkyl groups;

Y is O, NH, NHR.sup.9 or CHR.sup.9;

Z is S(.dbd.O).sub.2, S(.dbd.O), S, or C(.dbd.O)

j is 0, 1 or 2;

Q is H, C(.dbd.O)NHR.sup.9, C(.dbd.O)OR.sup.9, CH.dbd.N.sub.2, or CH.sub.2 R.sup.10;

R.sup.9 is hydrogen, alkyl having from one to about 10 carbons, said alkyl groups being optionally substituted with one or more K groups, aryl having from about 6 to about 14 carbons, or aralkyl having from about 7 to about 15 carbons;

R.sup.10 is aryloxy, heteroaryloxy, L, halogen, or has the formula O--M, wherein M has the structure: ##STR31## wherein: R is N or CR.sup.11;

W is a double bond or a single bond;

D is C.dbd.O or a single bond;

E and F are independently R.sup.12, R.sup.13, or J;

or E and F taken together comprise a joined moiety, said joined moiety being an aliphatic carbocyclic ring optionally substituted with J and having from 5 to 7 carbons, an aromatic carbocyclic ring optionally substituted with J and having from 5 to 7 carbons, an aliphatic heterocyclic ring optionally substituted with J and having from 5 to 7 atoms, or an aromatic heterocyclic ring optionally substituted with J and having from 5 to 7 atoms, said aliphatic heterocyclic ring or said aromatic heterocyclic ring each having from 1 to 4 heteroatoms;

R.sup.11, R.sup.12, and R.sup.13 are independently H, alkyl having from 1 to 10 carbons, heteroaryl having from 1 to 10 carbons, alkanoyl having from 1 to 10 carbons, or aroyl, wherein said alkyl, heteroaryl, alkanoyl and aroyl groups are optionally substituted with J;

J is halogen, C(.dbd.O)OR.sup.14, R.sup.14 OC(.dbd.O), R.sup.14 OC(.dbd.O)NH, OH, CN, NO.sub.2, NR.sup.14 R.sup.15, N.dbd.C (R.sup.14) R.sup.15, N.dbd.C(NR.sup.14 R.sup.15).sub.2, SR.sup.14, OR.sup.14, phenyl, naphthyl, heteroaryl, or a cycloalkyl group having from 3 to 8 carbons;

R.sup.14 and R15 are independently H, alkyl having from 1 to 10 carbons, aryl, or heteroaryl, wherein said alkyl, aryl and heteroaryl groups are optionally substituted with K;

L is a phosphorus-containing enzyme reactive group having the formula: ##STR32## wherein: m, n, and b are each independently 0 or 1;

R.sup.16 and R.sup.17 are each independently hydrogen, lower alkyl optionally substituted with K, aryl optionally substituted with K, or heteroaryl optionally substituted with K;

or R.sup.16 and R.sup.17 taken together with --(O).sub.N --P(.dbd.O)--(O).sub.m -- can form a 5-8 membered ring containing up to 3 hetero atoms;

or R.sup.6 and R.sup.17 taken together with --(O).sub.n --P(.dbd.O)--(O).sub.m -- can form a 5-8 membered ring optionally substituted with K.

47. The compound of claim 1 wherein Z is SO.

48. The compound of claim 1 wherein Z is S.

49. The compound of claim I wherein Q is CH.sub.2 R.sup.10.

50. The compound of claim 49 wherein R.sup.10 is --O--M.

51. The compound of claim 49 wherein R.sup.10 is -L.

52. The compound of claim 1 wherein Q is H.

53. The bisulfite addition product of the compound of claim 52.